
Fully Human Antibodies, Acceleration of Discovery & Development
Mission

Individual Project Design, Fee for Service or Milestone-based
Contract Research, R&D Services

Partnered R&D, Collaborations, Licensing
Pipeline & Partnering
YUMAB is a world leading provider of contract research, technologies, and R&D services for the development of fully human, therapeutic antibodies. The YUMAB® platform is based on almost 30 years of continuous research by its founders in antibody discovery and engineering. It combines state of the art and next generation technologies from target to lead under one roof. YUMAB offers individually designed projects and business solutions for small biotech start-ups up to large biopharma companies.
YUMAB celebrates 10th anniversary
January 10, 2023
What began as an academic start-up with the mission to facilitate biomedical translation is now a globally operating biotech company and a trusted service partner for therapeutic antibody development.
YUMAB offers contract research, technologies and R&D services for the discovery and development of fully human, therapeutic antibodies.
YUMAB also provides partnering and collaboration strategies to provide access to our technologies and expertise for academic spin-offs and start-up companies without the burden of technology access fees.
Phone: (+49) 531-481170-0
Email: info@yumab.com
1100 South Tower
225 Peachtree Street NE
Atlanta, GA 30303 – USA
Phone: (+49) 531 481170-0
Email: info@yumab.com